HealthEquity, Inc. (HQY)
NASDAQ: HQY · IEX Real-Time Price · USD
79.04
-0.16 (-0.20%)
At close: Apr 25, 2024, 4:00 PM
75.65
-3.39 (-4.29%)
Pre-market: Apr 26, 2024, 8:03 AM EDT
HealthEquity Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for HealthEquity stock have an average target of 95.45, with a low estimate of 72 and a high estimate of 110. The average target predicts an increase of 20.76% from the current stock price of 79.04.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HealthEquity stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 1 | 1 | 1 | 3 | 3 |
Buy | 5 | 6 | 6 | 6 | 7 | 8 |
Hold | 1 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 7 | 7 | 7 | 10 | 11 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Initiates $101 | Buy | Initiates | $101 | +27.78% | Apr 4, 2024 |
JP Morgan | JP Morgan | Buy Maintains $86 → $108 | Buy | Maintains | $86 → $108 | +36.64% | Apr 2, 2024 |
Keybanc | Keybanc | Buy Maintains $85 → $95 | Buy | Maintains | $85 → $95 | +20.19% | Mar 22, 2024 |
Barrington Research | Barrington Research | Buy Maintains $100 | Buy | Maintains | $100 | +26.52% | Mar 22, 2024 |
BTIG | BTIG | Strong Buy Maintains $100 → $110 | Strong Buy | Maintains | $100 → $110 | +39.17% | Mar 20, 2024 |
Financial Forecast
Revenue This Year
1.17B
from 999.59M
Increased by 16.75%
Revenue Next Year
1.33B
from 1.17B
Increased by 13.71%
EPS This Year
2.93
from 0.64
Increased by 357.53%
EPS Next Year
3.67
from 2.93
Increased by 25.27%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 1.2B | 1.4B | 1.5B |
Avg | 1.2B | 1.3B | 1.4B |
Low | 1.1B | 1.2B | 1.3B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 21.9% | 23.3% | 16.4% |
Avg | 16.7% | 13.7% | 8.5% |
Low | 12.4% | 7.0% | -5.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | 3.14 | 4.02 | 4.98 |
Avg | 2.93 | 3.67 | 4.39 |
Low | 2.78 | 3.31 | 3.65 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 390.5% | 37.3% | 35.7% |
Avg | 357.5% | 25.3% | 19.7% |
Low | 334.9% | 13.1% | -0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.